Zubin Punthakee

Zubin Punthakee is an Associate Professor in the Department of Endocrinology & Metabolism within the Faculty of Medicine at McMaster University. His scholarly activity spans over 30 years with 97 publications in the last 10 years, demonstrating sustained research productivity in diabetes, endocrine disorders, and metabolic health.

Dr. Punthakee's research interests focus on several key areas in endocrinology and diabetes care. He has made significant contributions to understanding type 2 diabetes remission through metabolic interventions, transition care for adolescents with type 1 diabetes moving to adult care systems, hypoparathyroidism management and skeletal health outcomes, and health disparities among South Asian populations. His work often involves large-scale clinical trials, registry-based research (particularly the Canadian National Hypoparathyroidism Registry), and implementation science approaches to improve diabetes care delivery.

Analysis of his recent publications reveals a strong focus on diabetes remission strategies, transition care quality improvement, and skeletal complications of endocrine disorders. His work bridges clinical endocrinology with health services research, often examining how to translate evidence into practice through audit and feedback mechanisms and structured transition programs.

Dr. Punthakee has been actively involved in numerous clinical trials including the REMIT-iGlarLixi trial examining diabetes remission, and has contributed to major clinical practice guidelines for diabetes management across the lifespan. His work with the Canadian National Hypoparathyroidism Registry has produced multiple publications characterizing the etiology, clinical manifestations, and management strategies for hypoparathyroidism.

His research frequently addresses health disparities, particularly among South Asian populations in Canada, examining factors like vaccine effectiveness, dietary patterns, and cardiovascular risk. This work demonstrates his commitment to addressing health equity through rigorous clinical research.